Financial Results for quarter ended 30.06.2026.

Regd. & Corporate Office : 'Venkateshwara House', S.No. 114/4J2, Pune-Sinhagad Road, Pune41 I 030, lndia 1g Phone: 020 - 7125'1530 to 32 Fa\ : O20 - 2425 1077 ,2425 1060 Venky's (India) Limited www.venkys.com CIN : 101222PN1976P1C017422 llth August,2026 The National Stock Exchange of India Limited, Bombay Stock Exchange limited, 'Exchange Plaza', Phiroze Jeejeebhoy Towers, Bandra-Kurla Complex, Bandra (E), Dalal Street, Mumbai - 400 051 . Mumbai - 400 001. Dear Sir, Subject: Audited Financial Results for the quarter ended 30th Jure, 2026 - Venky,s (India) Limited. Ref: - Scrip Code (i) Bombay Stock Exchange Limited - 523261 (iD National Stock Exchange of India Limited - VENKEYS Pursuant to Regulation 33(3)(a) Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith Audited Financial Results of Venky's (India) Limited for the quarter ended 30th June, 2026 which were reviewed by the Audit Committee and approved and taken on record by the Board of Directors at their respective meetings, held on 11'h August.2026. The aforesaid Board Meeting commenced at 10.30. A.M. IST and was concluded at 02:00 p.m. IST. Kindly take the said documents on your records and acknowledge receipt ofthe same. FOR \aENKY'S (INDIA) LTMITED ROHAN GWAT COMPAIIY SECRETARY & COMPLIANCE OFFICER Encl: As above VENKY'S (INDIA) LIMITED STATEMENT OF FINANCIAT RESUTTS FOR THE QUARTER ENDED 3OTH JUNE, 2026 ees in Lakhs) Quarter Ended Year Ended Particulars 30l06l2026 37/0312026 30l06l2O2s 3710312026 (Audited) (Audited) (Audited) (Audited) Rs. Rs. Rs. Rs. INCOME Revenue from operations 1,r1,838 7,10,047 86,583 3,7 2,732 Other income 1,349 t,573 1,169 4,767 TOTAL TNCOME (t) Lt3,ra7 1,,77,620 87 ,7 52 3,77,493 EXPENSES Cost of materials consumed 78,297 7r,110 55,308 2,52,059 Purchases of bearer biolo8ical assets 2,008 7,t94 L,502 5,496 Purchases of stock-in-trade 6,985 7,355 7,902 24,684 Changes in inventories of finished goods, work-in- 12,82Ll (1,s70) 2,73t (2,389) progress, stock-in-trade and biological assets Employee benelits expense 6,792 6,7l-t 6,323 25,927 Finance costs 394 340 429 1,704 Depreciation and amortisation expense 945 937 927 3,7r0 Other expenses 13,559 72,265 11,059 47,7 47 TOTAL EXPENSES (I) 1,05,260 98,348 85,575 3,58,938 PROFTT EEFORE TAX (r-rD 6,927 13,272 2,177 18,555 Less: Tax expense : Current tax 1,860 3,228 500 4,649 D,eferred tax 68 (e3) 94 (le) Tax adjustment in respect of earlier period Sub Total 1,928 3,135 594 4,630 PROFIT FOR THE PERIOD (A) 4,999 10,137 1,583 8,925 OTHER COMPREHENSIVE INCOME Items that will not be reclasslfled to prollt or loss Re-measurement gains/(losses) on dellned benefi t (621) (621) plans' Less: lncome tax (1s6) (1s6) Sub Total (46s) (46s) OTHER COMPREHENSIVE INCOME TOR THE PERIOD (B) (46s ) I (46s) TOTAT COMPREHENSIVE INCOME FOR THE PERIoD (A+B} 4,999 9,672 1,583 13,460 Paid-up equity share capital (Face Value of I 1Ol- each) 1,409 t,409 r,409 1,409 Other equity 1,58,200 Earnings per share ( Nomlnal Value of Share: t lO/- per equity share! (* not annualisedl (a) Basic 35.49 7 L.96 17.24 98.85 (b) 0iluted 35.49 71.96 7/7i.2\4,-.-._ 98.8s Npi4) s Based on the actuarial valuation report taken by the Company on annual basis venky's (lndial l-imited Segment lntormatlon Rupees in Lakhs) Particulars Quarter Ended Year Ended 3010612026 3t/0312026 30106/2025 37103/2026 (Audited) (Auditedl (Audited) (Audltedl Rs, Rs. Rs. Rs. 1 SEGMENT REVENUE a. Poultry and Priultry Products 51,689 55,236 47,566 7,89,675 b. Animal Health Products 1r,357 10,595 9,698 39,764 c. Oilseed 52,797 47 ,65r 31,802 1,55,414 Total t,ts,847 L,t3,482 89,066 3,84,253 Less: lnter-segment Revenue 4,009 3,435 2,483 11,521 Revenue From Operations 1,11,838 7,to,041 86,583 3,72,732 2 SEGMENT RESULTS Proflt/(tossl before tar and interest a. Poultry and Poultry Products 1,625 8,079 (s66) 5,545 b. Animal Health Products 3,031 3,113 23r8 9,899 c. Oilseed 3,096 2,518 1,005 5,438 Total 7,752 13,710 2,757 21,883 Less: (i) lnterest 394 340 429 7,704 (ii) Other unallocable expenditure net of unallocable 431 98 151 7,624 income Total Profit Sefore Tax 6,927 t3,272 2,177 18,555 3 SEGMENT AS5ETs a. Poultry and Poultry Products 90,545 85,333 80,604 85,333 b. Animal Health Products 23,786 23,336 27 ,49s 23,336 c. Oilseed 79,949 75,830 65,854 75,830 Total 7,94,280 7,84,499 1,73,953 7,84,499 d. Unallocable assets 42,7 25 46,367 35,162 46,367 Total Assets 2,37,OO5 2,30,866 2,O9,L75 2,30,855 4 SEGMENT TIABITITIES a. Poultry and Poultry Products 27,194 29,390 25,397 29,390 b. Animal Health Products 7,45L 5,933 6,643 5,933 c. Oilseed 15,504 L3,644 5,645 13,644 Total 50,149 48,967 37,679 48,967 d. Unallocable l-iabilities zI 22,248 22,290 22,296 22,290 Total Liabilities 72,397 71,,257 59,975 77,2s7 NOTES: For the quarter ended 30s June, 2026, the Company perfiormed well in all the three business segments, as under : a) Improved volume and better realization have helped the Poultry & Poultry Products Segnent's good performance, in spite ofhigher feed prices. b) Animal Health Products Segment continued to post good result on higher volurne and better product-mix. c) Oilseed Segment continued to perform well on higher volume and better cost . optimization measures. 2. The above results and notes thereon were perused by the Audit Committee and thereafter approved by the Board of Directors at their respective meetings held on l ls August, 2026 and further submitted to the statutory auditors for providing their audit report. 3. Previous yearlperiod figures are regtouped/reclassified to conform to the current year's presentation. Place: Pune For Venky's (India) Limited Date: l lth August, 2026 t B. Balaji Rao Managing Director DIN: 00013551 INDEPENDENT AUDITOR’S REPORT TO THE BOARD OF DIRECTORS OF VENKY’S (INDIA) LIMITED Report on the audit of the Financial Results Opinion We have audited the accompanying quarterly financial results of Venky’s (India) Limited (“the Company”) for the quarter ended 30th June, 2026 (“the financial results”), attached herewith, being submitted by the Company pursuant to the requirement of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (“Listing Regulations”). In our opinion and to the best of our information and according to the explanations given to us these financial results: i. are presented in accordance with the requirements of Regulation 33 of the Listing Regulations in this regard; and ii. give a true and fair view in conformity with the recognition and measurement principles laid down in the applicable Indian Accounting Standard 34 “Interim Financial Reporting” (“IND AS 34”) prescribed under section 133 of the Companies Act, 2013 (“the Act”) read with relevant rules issued thereunder and other accounting principles generally accepted in India of the net profit and other comprehensive income and other financial information for the quarter ended 30th June, 2026. Basis for Opinion We conducted our audit in accordance with the Standards on Auditing (SAs) specified under section 143(10) of the Act. Our responsibilities under those SAs are further described in the Auditor’s Responsibilities for the Audit of the financial results section of our report. We are independent of the Company in accordance with the Code of Ethics issued by the Institute of Chartered Accountants of India together with the ethical requirements that are relevant to our audit of the financial results under the provisions of the Act and the Rules thereunder, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the Code of Ethics. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion. Management and Those Charged with Governance Responsibilities for the financial results These financial results have been prepared on the basis o [Showing first 8,000 characters — download PDF for full document]